|
|
Article: ABIOMED Statement On Setback Suffered by Robert Tools, First AbioCor Patient.
- Article from:
- Business Wire
- Article date:
- November 14, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors and Health/Medical Writers
DANVERS, Mass.--(BW HealthWire)--Nov. 14, 2001
ABIOMED, Inc. (NASDAQ:ABMD), developers of the AbioCor(TM) Implantable Replacement Heart, today issued the following statement by Dr. David M. Lederman, Chief Executive Officer, concerning the status of Robert Tools, who suffered a serious stroke on Sunday, November 11:
"The thoughts and hopes of every ABIOMED employee are with Bob Tools and his family as he confronts this new challenge. If fighting spirit can make a difference, we know that Bob will make the fullest possible recovery.
Currently there is insufficient information to determine the ...